Feroli‑Consultancy is a boutique advisory firm dedicated to helping pharmaceutical and biotech companies successfully bring complex therapies—especially rare disease treatments —to patients across Europe.
With deep experience in the Benelux and other EU markets, Feroli supports companies from early market assessment to full commercial rollout, ensuring that every step of the launch journey is strategically aligned and operationally flawless.Our Expertise
Rare Diseases
Launching rare disease therapies requires sensitivity, precision, and an intimate understanding of access barriers.
Feroli‑Consultancy brings hands‑on experience with:
- Mapping patient journeys and diagnostic pathways
- Building payer and clinician engagement strategies
- Navigating early access, reimbursement, and real‑world evidence needs
- Coordinating medical, regulatory, and commercial stakeholders in small but complex markets
Biosimilars
With a proven track record in several biosimilar launches, we help clients optimize their strategy amid intense competition and fast‑shifting tender dynamics.
Our support includes:
- Tender logic and price‑corridor modelling
- Hospital contracting strategies (including Belgium's biocliff dynamics)
- Competitive landscape assessments
- Distribution and wholesale onboarding for fast market scalability
Launch Consulting
Feroli‑Consultancy transforms launch planning into launch success.
We provide end‑to‑end guidance, from strategy to execution, including:
- Market access roadmaps and reimbursement strategy
- Cross‑functional launch frameworks tailored to local reality
- Communication flows between HQ, affiliates, and field teams
- Pre‑launch readiness dashboards, KPIs, and governance
- Scenario planning for pricing, supply, and stakeholder engagement